Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study

Journal of Psychopharmacology

Volumn 28, Issue 1, 2014, Pages 23-30

  Caputo, Fabio ^a,b   Del Re, Arfedele ^c   Brambilla, Romeo ^d,e   Grignaschi, Alice ^b   Vignoli, Teo ^f   Vigna Taglianti, Federica ^d,e   Addolorato, Giovanni ^g   Zoli, Giorgio ^a   Cibin, Mauro ^h   Bernardi, Mauro ^b  

^a SS Annunziata Hospital   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Addiction Treatment Centre   (Italy)

^d Piedmont Centre for Drug Addiction Epidemiology   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f Unit for Addiction Treatment   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h NONE   (Italy)

Author keywords

craving for alcohol; craving for sodium oxybate; Lesch alcoholism typology; Pharmacotherapy of alcohol dependence; sodium oxybate

Indexed keywords

MOOD STABILIZER; OXYBATE SODIUM; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LESCH ALCOHOLISM TYPOLOGY; MALE; MIDDLE AGED; PATIENT COUNSELING; PILOT STUDY; PRIORITY JOURNAL; PSYCHOSIS; RELAPSE; RISK; SCORING SYSTEM; SEDATION; SOCIAL WORK; SOMNOLENCE; TREND STUDY; VERTIGO; WITHDRAWAL SYNDROME; BEHAVIOR, ADDICTIVE; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; YOUNG ADULT;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; BEHAVIOR, ADDICTIVE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GABA AGONISTS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; SODIUM OXYBATE; YOUNG ADULT;

EID: 84889240896     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113504015     Document Type: Article

References (34)

1. Addolorato G, Leggio L, Ferrulli A, et al. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: Balancing the risks and benefits. A focus on clinical data. Expert Opin Investig Drugs. 2009 ; 18: 675-686
2. Agabio R, Colombo G, Loche A, et al. Gamma-hydroxybutyric acid reducing effect on ethanol intake: Evidence in favour of a substitution mechanism. Alcohol Alcohol. 1998 ; 33: 465-474 (Pubitemid 28477179)
3. Diagnostic and Statistical Manual of Mental Disorders. 2000 ) Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text revision. Washington DC: American Psychiatric Association. Washington DC: American Psychiatric Association ; 2000:
4. Caputo F, Bernardi M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr Pharm Des. 2010 ; 16: 2118-2125
5. Caputo F, Addolorato G, Stoppo M, et al. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study. Eur Neuropsychopharmacol. 2007 ; 17: 781-789 (Pubitemid 47588865)
6. Caputo F, Francini S, Brambilla R, et al. Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity. Eur Neuropsychopharmacol. 2011 ; 21: 450-456
7. Caputo F, Francini S, Stoppo M, et al. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: An open comparative study. J Psychopharmacol. 2009 ; 23: 883-890
8. Cigarette SOking among adults-United States. Morb Mortal Wkly Rep. 2001 1999 ; 50: 869-873
9. Colombo G, Agabio R, Lobina C, et al. Cross-tolerance to ethanol and gamma-hydroxybutyric acid. Eur J Pharmacol. 1995 ; 273: 235-238
10. Da Penha Zago-Gomes M, Nakamura-Palacios EM. Cognitive components of frontal lobe function in alcoholics classified according to Lesch's typology. Alcohol Alcohol. 2009 ; 44: 449-457
11. Di Nicola M, Martinotti G, Tedeschi D, Frustaci A, et al. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Hum Psychopharmacol. 2010 ; 25: 268-275
12. Friedmann PD. Alcohol use in adults. N Engl J Med. 2013 ; 368: 365-373
13. Gallimberti L, Ferri M, Ferrara SD, et al. gamma-Hydroxybutyric acid in the treatment of alcohol dependence: A double-blind study. Alcohol Clin Exp Res. 1992 ; 16: 673-676
14. Gessa GL, Agabio R, Carai M, et al. Mechanism of the anti-alcohol effect of gamma-hydroxybutyric acid (GHB). Alcohol. 2000 ; 20: 271-276 (Pubitemid 30408576)
15. Gobaille S, Schleef C, Hechler V, et al. Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain. Life Sci. 2002 ; 70: 2101-2112 (Pubitemid 34219461)
16. Hesse S, Barthel H, Schwarz J, et al. Advances in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci Biobehav Rev. 2004 ; 28: 547-563 (Pubitemid 39446481)
17. Hillemacher T, Bayerlein K, Wilhelm J, et al. Recurrent detoxifications are associated with craving in patients classified as type 1 according to Lesch's typology. Alcohol Alcohol. 2006 ; 41: 66-69 (Pubitemid 43091626)
18. Johnson BA, Roache JD, Javors MA, et al. Ondasetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial. JAMA. 2000 ; 284: 963-971 (Pubitemid 30659126)
19. Kiefer F, Jiménez-Arriero MA, Klein O, et al. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Add Biol. 2007 ; 13: 124-129 (Pubitemid 351202130)
20. Leggio L, Kenna GA, Fenton M, et al. Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev. 2009 ; 19: 115-129
21. Lehert P. Review and discussion of statistical analysis of controlled clinical trials in alcoholism. Alcohol Alcohol. 1993 ; 28: 157-163
22. Leone MA, Vigna-Taglianti F, Avanzi G, et al. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst Rev. 2010 ; 2: CD006266
23. Lesch KP. Alcohol dependence and gene x environment interaction in emotion regulation: Is serotonin the link?. Eur J Pharmacol. 2005 ; 526: 113-124
24. Lesch OM, Walter H. Subtypes of alcoholism and their role in therapy. Alcohol Alcohol. 1996 ; 31: 63-67 (Pubitemid 26150747)
25. Lesch OM, Dietzel M, Musalek M, et al. The course of alcoholism. Long-term prognosis in different types. Forensic Sci Int. 1988 ; 36: 121-138 (Pubitemid 18007491)
26. Lesch OM, Riegler A, Gutierrez K, et al. The European acamprosate trials: Conclusions for research and therapy. J Biomed Sci. 2001 ; 8: 89-95 (Pubitemid 32098490)
27. Maremmani AG, Pani PP, Rovai L, et al. Long-term y-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics. Int J Environ Res Public Health. 2011 ; 8: 2816-2827
28. Martinotti G, Di Nicola M, Romanelli R, et al. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Hum Psychopharmacol. 2007 ; 22: 149-156 (Pubitemid 46730583)
29. Nakamura-Palacios EM, de Almeida Benevides MC, da Penha Zago-Gomes M, et al. Auditory event-related potentials (P3) and cognitive changes induced by frontal direct current stimulation in alcoholics according to Lesch alcoholism typology. Int J Neuropsychopharmacol. 2012 ; 15: 601-616
30. Pardi D, Black J. gamma-Hydroxybutyrate/GHB: Neurobiology, and impact on sleep and wakefulness. CNS Drugs. 2006 ; 20: 993-1018 (Pubitemid 44912708)
31. Pombo S, Lesch OM. The alcoholic phenotypes among different multidimensional typologies: Similarities and their classification procedures. Alcohol Alcohol. 2009 ; 44: 46-54
32. Snead OC III, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med. 2005 ; 352: 2721-2732
33. Stockmeier CA. Involvement of serotonin in depression: Evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res. 2003 ; 37: 353-357
34. Wetzler S, Marlowe DB. The diagnosis and assessment of depression, mania, and psychosis by self-report. J Pers Assess. 1993 ; 60: 1-31